Jeffrey Lipman's Publications

About Jeffrey Lipman's Publications

Honorary Professorial Fellow

  • Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis

    Expert Opinion on Drug Metabolism & Toxicology Date published:

  • New guidelines for the management of severe thermal burns in the acute phase in adults and children: Is it time for a global surviving burn injury campaign (SBIC)?

    Anaesthesia Critical Care & Pain Medicine Date published:

  • COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics

    Anaesthesia Critical Care & Pain Medicine Date published:

  • Corrigendum to “Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study” [Journal of Critical Care 52 (2019) 75-79]

    Journal of Critical Care Date published:

  • Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid

    Anesthesia & Analgesia Date published:

  • The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study

    Clinical Infectious Diseases Date published:

  • Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime

    Clinical Pharmacokinetics Date published:

  • β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis

    International Journal of Antimicrobial Agents Date published:

  • There is no fire without smoke! Pathophysiology and treatment of inhalational injury in burns: A narrative review

    Anaesthesia and Intensive Care Date published:

  • Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU

    Intensive Care Medicine Date published:

  • Ventilator-Associated Tracheobronchitis: To Treat or Not to Treat?

    Antibiotics Date published:

  • Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms

    Microorganisms Date published:

  • Antimicrobial-associated harm in critical care: a narrative review

    Intensive Care Medicine Date published:

  • Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei

    Nature Communications Date published:

  • When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit

    Clinical Microbiology and Infection Date published:

  • Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients

    Antimicrobial Agents and Chemotherapy Date published: